Cancer Screening in Inflammatory Bowel Disease

1. Front Matter

   Pages i-xi

   PDF

2. Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases

   • Sanjay K. Murthy, Geoffrey C. Nguyen

   Pages 1-15

3. Screening for Colon Cancer in Inflammatory Bowel Disease

   • Kendall Beck, Fernando Velayos

   Pages 17-31

4. Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease

   • Reid L. Hopkins, Jamie Abbott, Debjani Sahni, Francis A. Farraye

   Pages 33-53

5. Female-Specific Cancer Risks and Screening in Inflammatory Bowel Disease

   • Kara De Felice, Sunanda Kane

   Pages 55-60

6. Lymphoma Risk and Screening in IBD

   • Chip Alex Bowman, Garrett Lawlor

   Pages 61-73

7. Pouch Neoplasia Following IPAA in Patients with Underlying Inflammatory Bowel Diseases

   • Freeha Khan, Bo Shen

   Pages 75-83

8. Other Cancers: Small-Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease

   • Fernanda Dal Bello, Alan C. Moss

   Pages 85-93

9. Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases

   • Helen Lee, Yecheskel Schneider, Gary R. Lichtenstein

   Pages 95-108

10. Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches

    • Siddharth Singh

    Pages 109-118

11. Cancer Risk and Screening in Pediatric Patients

    • Matthew Kowalik, Stacy A. Kahn

    Pages 119-130

12. Colorectal Cancer Risk and Screening in Geriatric Patients

    • Elissa Lin, Seymour Katz

    Pages 131-163

13. Use of Biologic Drugs Following an Initial Diagnosis of Malignancy

    • Jordan Axelrad, Shannon Chang, David Hudesman

    Pages 165-167

14. Back Matter

    Pages 169-174

    PDF

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. 


Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

• colon cancer
• small bowel cancer
• cervical cancer
• skin cancer
• lymphoma
• cholangiocarcinoma

• Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, USA

  Joseph D. Feuerstein, Adam S. Cheifetz

Joseph D. Feuerstein, MD
Beth Israel Deaconess Medical Center
Center for Inflammatory Bowel Disease
Harvard Medical School
Boston, MA
USA


Adam S. Cheifetz, MD
Beth Israel Deaconess Medical Center
Center for Inflammatory Bowel Disease
Harvard Medical School
Boston, MA
USA

Policies and ethics